Your browser doesn't support javascript.
loading
Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial.
Traboulsee, Anthony; Greenberg, Benjamin M; Bennett, Jeffrey L; Szczechowski, Lech; Fox, Edward; Shkrobot, Svitlana; Yamamura, Takashi; Terada, Yusuke; Kawata, Yuichi; Wright, Padraig; Gianella-Borradori, Athos; Garren, Hideki; Weinshenker, Brian G.
Afiliación
  • Traboulsee A; Department of Neurology, University of British Columbia, Vancouver, BC, Canada. Electronic address: t.traboulsee@ubc.ca.
  • Greenberg BM; Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Bennett JL; Departments of Neurology and Ophthalmology, University of Colorado School of Medicine, Aurora, CO, USA.
  • Szczechowski L; Silesian Centre of Neurology, Medical University of Silesia, Katowice, Poland.
  • Fox E; Central Texas Neurology Consultants, Round Rock, TX, USA.
  • Shkrobot S; Department of Neurology, Psychiatry, Narcology and Medical Psychology, Ternopil State Medical University, Ternopil, Ukraine.
  • Yamamura T; Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Terada Y; Chugai Pharmaceutical, Tokyo, Japan.
  • Kawata Y; Chugai Pharmaceutical, Tokyo, Japan.
  • Wright P; Chugai Pharma Europe, London, UK.
  • Gianella-Borradori A; Servier Laboratories, Suresnes, Paris, France.
  • Garren H; Genentech, South San Francisco, CA, USA.
  • Weinshenker BG; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Lancet Neurol ; 19(5): 402-412, 2020 05.
Article en En | MEDLINE | ID: mdl-32333898

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neuromielitis Óptica / Anticuerpos Monoclonales Humanizados / Inmunosupresores Tipo de estudio: Clinical_trials / Guideline Idioma: En Revista: Lancet Neurol Asunto de la revista: NEUROLOGIA Año: 2020 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neuromielitis Óptica / Anticuerpos Monoclonales Humanizados / Inmunosupresores Tipo de estudio: Clinical_trials / Guideline Idioma: En Revista: Lancet Neurol Asunto de la revista: NEUROLOGIA Año: 2020 Tipo del documento: Article